Tokyo, April 28 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061391) titled 'Effects of Moxibustion on chronic neck and shoulder pain (katakori) and Postural Control' on April 27.
Study Type:
Interventional
Study Design:
Basic Design - Cross-over
Randomization - Randomized
Blinding - Open -but assessor(s) are blinded
Control - No treatment
Primary Sponsor:
Institute - Teikyo Heisei University
Condition:
Condition - chronic neck and shoulder pain (katakori)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The aim of this study is to investigate whether moxibustion can be a useful intervention for workers with chronic neck and shoulder pain (katakori).
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Moxibustion
Interventions/Control_2 - No treatment
Eligibility:
Age-lower limit - 18
years-old
Gender - Male and Female
Key inclusion criteria - 1. Individuals in whom no apparent organic disease is identified on health examination.
2. Individuals with moderate chronic neck and shoulder pain (katakori), defined as a Numerical Rating Scale (NRS) score of 4/10 or higher, persisting for at least 3 months.
3. Individuals with no abnormal neurological findings in the upper extremities, including deep tendon reflexes, muscle strength, and sensory testing.
Key exclusion criteria - 1. Individuals with abnormalities of the vestibular or visual system.
2. Individuals with a history of spinal surgery.
3. Individuals with rheumatic diseases.
4. Individuals with diseases affecting the spine.
5. Individuals with any other disease or injury affecting the cervical region.
6. Pregnant individuals.
7. Individuals currently participating in another clinical trial or investigational study.
8. Individuals with a history of allergic reactions to pharmaceuticals or cosmetics (e.g., rash, redness, itching, or dermatitis).
9. Individuals with fragile or sensitive skin (e.g., diseased, sensitive, or unstable skin).
10. Individuals with a mugwort allergy.
11. Individuals who are sensitive to smoke or odors.
12. Individuals judged by the investigator to be unsuitable for participation in the study.
Target Size - 34
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2026 Year 03 Month 19 Day
Date of IRB - 2026 Year 03 Month 19 Day
Anticipated trial start date - 2026 Year 04 Month 27 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070241
Disclaimer: Curated by HT Syndication.
